Skip to main content

Jennifer Herington

Department of Pediatrics, Division of Neonatology
Department of Pharmacology
The Vanderbilt Pre3 Initiative: Preventing adverse pregnancy outcomes and prematurity

Our research is focused on interventional approaches to regulate uterine contractions for either the management of preterm labor or postpartum hemorrhage. Our laboratory has established a drug discovery strategy to identifying novel regulators of uterine myometrial contractility. We are equipped for high-throughput screening of small-molecules, prioritization of hits into leads using secondary assays and pre-clinical in vivo testing in mouse models.

Keywords: drug discovery , pregnancy , women's health , high-throughput screening , drug repurposing

Research Area: Chemical Biology , Molecular Pathology